Cell cycle genes in chondrocyte proliferation and differentiation

Matrix Biology

Volumn 18, Issue 2, 1999, Pages 109-120

  Beier, Frank ^a   Leask, Todd A ^a   Haque, Shelby ^a   Chow, Christopher ^a   Taylor, Allison C ^a   Lee, Richard J ^b   Pestell, Richard G ^b   Ballock, R Tracy ^c   Luvalle, Phyllis ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Bone growth; Cell cycle; Chondrocytes; Differentiation; Proliferation

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR;

BONE DEVELOPMENT; CARTILAGE CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROGENESIS; ENCHONDRAL OSSIFICATION; GENE EXPRESSION; PRIORITY JOURNAL; REVIEW;

EID: 0032946503     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(99)00009-8     Document Type: Article

References (112)

1. Albanese C., Johnson J., Watanabe G.et al. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:1995;23589-23597.
2. Amati B., Land H. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation, and death. Curr. Biol. 4:1994;102-108.
3. Amati B., Alevizopoulos K., Vlach J. Myc and the cell cycle. Frontiers Biosci. 3:1998;d250-268.
4. Amizuka N., Warshawsky H., Henderson J.E., Goltzman D., Karaplis A.C. Parathyroid hormone-related peptide depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell. Biol. 126:1994;1611-1623.
5. Amling M., Neff L., Tanaka S.et al. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell. Biol. 136:1997;205-213.
6. Baker J., Liu J.-P., Robertson E.J., Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:1993;73-82.
7. Bartek J., Bartkova J., Lukas J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 8:1996;814-905.
8. Beier, F., Lee, R.J., Taylor, A.C., Pestell, R.G., LuValle, P., 1999. Identification of the cyclin D1 gene as a target of ATF-2 in chondrocytes. Proc. Nat. Acad. Sci., in press.
9. Beier, F., Taylor, A.C., LuValle, P., 1998a. Raf signaling stimulates and represses the human collagen X promoter through distinguishable elements. J. Cell. Biochem. in press.
10. Beier, F., Taylor, A.C., LuValle, P., 1998b. The Raf-1/MEK/ERK pathway regulates the expression of the p21Waf1/Cip1 gene in chondrocytes. Submitted.
11. Beijersbergen R.L., Hijmans E.M., Zhu L., Bernards R. Interaction of c-myc with the pRb-related p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:1994;4080-4086.
12. Bignon Y.-J., Chen Y., Chang C.-Y.et al. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 7:1993;1654-1662.
13. Bouchard C., Staller P., Eilers M. Control of cell proliferation by myc. Trends Cell Biol. 8:1998;202-206.
14. Braun T., Rudnicki M.A., Arnold H.H., Jaenisch R. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell. 71:1992;369-382.
15. Brown J.R., Nigh E., Ye H., Lee R.J., Pestell R.G., Greenberg M.E. Fos family members induce cell cycle entry by activating cyclin D1. Mol. Cell. Biol. 18:1998;5609-5619.
16. Cancedda R., Cancedda F.D., Castagnola P. Chondrocyte differentiation. Int. Rev. Cytol. 159:1995;265-358.
17. Capecchi M.R. Function of homeobox genes in skeletal development. Ann. N.Y. Acad. Sci. 785:1996;34-37.
18. Carrasco D., Bravo R. Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development. Oncogene. 10:1995;1069-1079.
19. Cobrinik D., Lee M.-H., Hannon G.et al. Shared role of the pRb-related p130 and p107 proteins in limb development. Genes Dev. 10:1996;1633-1644.
20. Davis A.C., Wims M., Spotts G.D., Hann S.R., Bradley A. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygous and reduced fertility in heterozygous female mice. Genes Dev. 7:1993;671-682.
21. Deng C., Zang P., Harper J.W., Elledge S.J., Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:1995;675-684.
22. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 84:1996;911-921.
23. Dynlacht B.D. Regulation of transcription by proteins that control the cell cycle. Nature. 389:1997;149-152.
24. Fero M.L., Rivkin M., Tasch M.et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:1996;733-744.
25. Foley K.P., McArthur G.A., Queva C., Hurlin P.J., Soriano P., Eisenman R.N. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17:1998;774-785.
26. Foulkes N.S., Sassone-Corsi P. Transcription factors coupled to the cAMP-signalling pathway. Biochim. Biophys. Acta. 1288:1996;F101-F121.
27. Fraichard A., Chassande O., Plateroti M.et al. The T3Rα gene encoding a thyroid hormone receptor is essential for postnatal development and thyroid hormone production. EMBO J. 16:1997;4412-4420.
28. Galaktionov K., Chen X., Beach Cdc D. 25 cell-cycle phosphatase as a target of c-myc. Nature. 382:1996;511.
29. Goff D.J., Tabin C.J. Analysis of Hoxd-13 and Hoxd-11 misexpression in chick limb bud reveals that Hox genes affect both bone condensation and growth. Development. 124:1997;627-636.
30. Gu W., Bhatia K., Magrath I., Dang C., Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107. Science. 264:1994;251-254.
31. Hall M., Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68:1996;66-108.
32. Harper J.W., Elledge S.J. Cdk inhibitors in development and cancer. Curr. Biol. 6:1996;56-64.
33. Henriksson M., Luescher B. Proteins of the myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:1996;109-182.
34. Hoyt M.A. Eliminating all obstacles: regulated proteolysis in the eukaryotic cell cycle. Cell. 91:1997;149-151.
35. Hurlin P., Queva C., Eisenman R.N. Mnt, a novel max-interacting protein is co-expressed with Myc in proliferating cells and mediates repression at myc binding sites. Genes Dev. 11:1997;44-58.
36. Innis J.W. Role of HOX genes in human development. Curr. Opin. Pediatr. 9:1997;617-622.
37. Iwamoto M., Yagami K., LuValle P.et al. Expression and role of c-myc in chondrocytes undergoing endochondral ossification. J. Biol. Chem. 268:1993;9645-9652.
38. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature. 359:1992;295-300.
39. Kameda T., Watanabe H., Iba H. c-Jun and JunD suppress maturation of chondrocytes. Cell Growth Diff. 8:1997;495-503.
40. Kaneko Y., Tanzawa H., Sato K. The proto-oncogene c-raf-1 is highly expressed only in the hypertrophic zone of the growth plate. Calcif. Tissue Int. 54:1994;426-430.
41. Karaplis A.C., Luz A., Glowacki L.et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8:1994;277-289.
42. Karin M., Liu Z.-G., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
43. Kiess M., Gill R.M., Hamel P.A. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 10:1995;159-166.
44. Kiyokawa H., Kineman R.D., Manova-Todorova K.O.et al. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721-732.
45. Kroon E., Krosl J., Thorsteinsdottir U., Baban S., Buchberg A.M., Sauvageau G. Hoxa9 transforms primary bone marrow cells through specific collaboration with meis1a but not pbx1b. EMBO J. 17:1998;3714-3725.
46. Lanske B., Karaplis A.C., Lee K.et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science. 273:1996;663-666.
47. Lau M.M.H., Stewart C.E.H., Liu Z., Bhatt H., Rotwein P., Stewart C.L. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev. 8:1994;2953-2963.
48. LeCouter J.E., Kablar B., Hardy W.R., Ying C., Megeney L.A., May L.L., Rudnicki M.A., 1998a. Strain-dependent myeloid metaplasia, growth-deficiency, and shortened cell-cycle in mice lacking p107. Mol. Cell. Biol. in press.
49. LeCouter J.E., Kablar B., White P.F.M., Ying C., Rudnicki M.A., 1998b. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development in press.
50. Lee E.Y.-H.P., Chang C.-Y., Hu N.et al. Mice deficient for Rb are non-viable and show defects in neurogenesis and haematopoiesis. Nature. 359:1992;288-294.
51. Lee M.-H., Williams B.O., Mulligan G.et al. Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev. 10:1996;1621-1632.
52. Lefebvre V., Garofalo S., Crombrugghe B.d. Type X collagen gene expression in mouse chondrocytes immortalized by a temperature-sensitive Simian Virus 40 Large Tumor Antigen. J. Cell. Biol. 128:1995;239-245.
53. Legeai-Mallet L., Benoist-Lassalin C., Delezoide A.L., Munnich A., Bonaventure J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem. 273:1998;13007-13014.
54. Lemaitre J.-M., Buckle R.S., Mechali M. c-myc in the control of cell proliferation and embryonic development. Adv. Cancer Res. 70:1996;95-144.
55. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:1998;49-139.
56. Li Y.C., Pirro A.E., Amling M.et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA. 94:1997;9831-9835.
57. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type I IGF receptor (IgfIr). Cell. 75:1993;59-72.
58. Liu M., Lee M.-H., Cohen M., Bommakanti M., Freedman L.P. Transcriptional activation of the cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153.
59. Mark M., Rijli F.M., Chambon P. Homeobox genes in embryogenesis and pathogenesis. Pediatr. Res. 42:1997;421-429.
60. Maroulakou I.G., Papas T.S., Green J.E. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene. 9:1994;1551-1565.
61. Meroni G., Reymond A., Alcalay M.et al. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with max, binds a non-canonical E box, and acts a a transcriptional repressor. EMBO J. 16:1997;2892-2906.
62. Meyyappan M., Wong H., Hull C., Riabowol K.T. Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol. Cell. Biol. 18:1998;3163-3172.
63. Missero C., Cunto F.D., Kiyokawa H., Koff A., Dotto G.P. The absence of p21Cip1/Waf1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev. 10:1996;3065-3075.
64. Mukhopadhyay K., Lefebvre V., Zhou G., Garofalo S., Kimura J.H., Crombrugghe B.d. Use of a new rat chondrosarcoma cell line to delineate a 119-base pair chondrocyte-specific enhancer element and to define active promoter segments in the mouse pro-alpha 1(II) collagen gene. J. Biol. Chem. 270:1995;27711-27719.
65. Mundlos S., Olsen B.R. Heritable diseases of the skeleton. Part 1: molecular insights into skeletal development - transcription factors and signaling pathways. Faseb J. 11:1997;125-132.
66. Mundlos S., Olsen B.R. Heritable diseases of the skeleton. Part II: molecular insights into skeletal development - matrix components and their homeostasis. Faseb J. 11:1997;227-233.
67. Nakamura T., Okuyama S., Okamoto S., Nakajima T., Sekiya S., Oda K. Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site. Exp. Cell Res. 216:1995;422-430.
68. Nakayama K., Ishida N., Shirane M.et al. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 85:1996;707-720.
69. Nilsson A., Ohlsson C., Isaksson O.G.P., Lindahl A., Isgaard J. Hormonal regulation of longitudinal bone growth. Eur. J. Clin. Nutr. 48:1994;S150-S160.
70. Park K., Choe J., Osifchin N.E., Templeton D.J., Robbins P.D., Kim S.-J. The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product. J. Biol. Chem. 269:1994;6083-6088.
71. Pestell R.G., Albanese C., Reutens A.T., Lee R.J., Arnold A., 1998. The cyclins and cyclin dependent kinases inhibitors in hormonal regulation of proliferation and differentiation. Endocrine Rev. in press.
72. Pfeifer A., Aszodi A., Seidler U., Ruth P., Hofmann F., Fassler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science. 274:1996;2082-2086.
73. Piette J. The transition from proliferation to differentiation in nerve cells: what can we learn from muscle? Exp. Cell Res. 234:1997;193-204.
74. Planas-Silva M.D., Weinberg R.A. The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9:1997;768-772.
75. Price J.S., Oyajobi B.O., Russell R.G.G. The cell biology of bone growth. Eur. J. Clin. Nutr. 48:1994;S131-S149.
76. Quarto R., Dozin B., Tacchetti C.et al. Constitutive myc expression impairs hypertrophy and calcification in cartilage. Dev. Biol. 149:1992;168-176.
77. Queva C., Hurlin P.J., Foley K.P., Eisenman R.N. Sequential expression of the MAD family of transcriptional repressors during differentiation and development. Oncogene. 16:1998;967-977.
78. Reimold A.M., Grusby M.J., Kosaras B.et al. Chondrodysplasia and neurological abnormalities in ATF-2 deficient mice. Nature. 379:1996;262-265.
79. Roussel M.F. Key effectors of signal transduction and G1 progression. Adv. Cancer Res. 74:1998;1-24.
80. Ruether U., Garber C., Komitowski D., Mueller R., Wagner E.F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature. 325:1987;412-416.
81. Sakai M., Imaki J., Yoshida K.et al. Rat maf related genes: specific expression in chondrocytes, lens and spinal cord. Oncogene. 14:1997;745-750.
82. Sanchez I., Dynlacht B.D. Transcriptional control of the cell cycle. Curr. Opin. Cell Biol. 8:1996;318-324.
83. Schreiber-Agus N., Meng Y., Hoang T.et al. Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature. 393:1998;483-487.
84. Serra R., Johnson M., Filvaroff E.H.et al. Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell. Biol. 139:1997;541-552.
85. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
86. Shimizu M., Nomura Y., Suzuki H.et al. Activation of the rat cyclin A promoter by ATF-2 and jun family members and its suppresion by ATF4. Exp. Cell Res. 239:1998;93-103.
87. Sicinski P., Donaher J.L., Parker S.B.et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell. 82:1995;621-630.
88. Sicinski P., Donaher J.L., Geng Y.et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 384:1996;470-474.
89. Stewart M.C., Farnum C.E., MacLeod J.N. Expression of p21CIP1/Waf1 in chondrocytes. Calcif. Tissue Int. 61:1997;199-204.
90. Su B., Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8:1996;402-411.
91. Su W.C., Kitagaw M., Xue N. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 386:1997;288-292.
92. Sumarsono S.H., Wilson T.J., Tymms M.J.et al. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature. 379:1996;534-537.
93. Sunters A., McCluskey J., Grigoriadis A.E. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation. Dev. Genet. 22:1998;386-397.
94. Thorsteinsdottir U., Sauvageau G., Hough M.R. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeolid leukemia. Mol. Cell. Biol. 17:1997;495-505.
95. Treisman R. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:1996;205-215.
96. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., Tabin C.J. Regulation of rate of cartilage differentiation by indian hedgehog and PTH-related protein. Science. 273:1996;613-622.
97. Wang Z.-Q., Grigoriadis A.E., Moehle-Steinlein U., Wagner E.F. A novel target cell for c-fos-induced oncogenesis: development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J. 10:1991;2437-2450.
98. Wang Z.-Q., Ovitt C., Grigoriadis A.E., Moehle-Steinlein U., Ruether U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741-745.
99. Wang Z.-Q., Fung M.R., Barlow D.P., Wagner E.F. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature. 372:1994;464-467.
100. Wasylyk B., Hagman J., Gutierrez-Hartmann A. Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem. Sci. 23:1998;213-216.
101. Watanabe H., Saitoh K., Kameda T. Chondrocytes as a specific target of ectopic fos expression in early development. Proc. Natl. Acad. Sci. USA. 94:1997;3994-3999.
102. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
103. Wilsman N.J., Farnum C.E., Green E.M., Lieferman E.M., Clayton M.K. Cell cycle analysis of proliferative zone chondrocytes in growth plates elongating at different rates. J. Orthop. Res. 14:1996;562-572.
104. Yan G.-Z., Ziff E.B. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1. J. Neurosci. 15:1995;6200-6212.
105. Yan G.Z., Ziff E.B. Nerve growth factor induces transcription of the p21WAF1/CIP1 and cyclin D1 genes in PC12 cells by activating Sp1 transcription factor. J. Neurosci. 17:1997;6122-6132.
106. Yan Y., Friesen J., Lee M.-H., Massague J., Barbacid M. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:1997;973-983.
107. Yee A.S., Shih H.H., Tevosian S.G. New perspectives on retinoblastoma family functions in differentiation. Frontiers Biosci. 3:1998;d532-547.
108. Yoshizawa T., Handa Y., Uematsu Y.et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nature Gen. 16:1997;391-396.
109. Yueh Y.G., Gardner D.P., Kappen C. Evidence for regulation of cartilage differentiation by the homeobox gene hoxc-8. Proc. Natl. Acad. Sci. USA. 95:1998;9956-9961.
110. Zacksenhaus E., Jiang Z., Chung D., Marth J.D., Phillips R.A., Gallie B.L. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:1996;3051-3064.
111. Zavitz K.H., Zipursky S.L. Controlling cell proliferation in differentiating tissues: genetic analysis of negative regulators of G1→S-phase progression. Curr. Opin. Cell Biol. 9:1997;773-781.
112. Zhang P.M., Liegeois N.J., Wong C.et al. Altered cell differentiation and proliferation in mice lacking p57(KIP2) indicates a role in Beckwith-Wiedemann syndrome. Nature. 387:1997;151-158.